Status:
COMPLETED
Handgrip and Respiratory Dysfunction in HD Patients.
Lead Sponsor:
General University Hospital, Prague
Conditions:
Huntington Disease
Eligibility:
All Genders
18-80 years
Brief Summary
Hereditary neurodegenerative diagnosis of Huntington's disease (HD) is associated with a progressive deterioration of the respiratory system function . This fact contributes strongly to the increased ...
Detailed Description
Goal: To identify a simple method for screening respiratory muscle and cough weakness in Huntington\'s Disease (HD) patients, suitable for clinical practice. Hypothesis 1: Maximal inspiratory pre...
Eligibility Criteria
Inclusion
- Genetic confirmed diagnosis of Huntington's disease
Exclusion
- diagnosis of other concomitant neurological diseases;
- a history of cardiovascular or lung disease;
- respiratory symptoms such as cough, phlegm, wheezing, or dyspnea at the time of assessment
Key Trial Info
Start Date :
April 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06585332
Start Date
April 1 2024
End Date
October 31 2024
Last Update
March 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General University Hospital
Prague, Czechia, Czechia, 12000